SV7 Impact Medicine Fund LP

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Kathleen R. Henry, pursuant to Power of Attorney for SV7 Impact Medicine Fund LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SV7 Impact Medicine Fund LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1,613,632 $1,339,315 $0.8300 26 Oct 2021 Direct
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1,613,632 $1,339,315 $0.8300 26 Oct 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 26 Oct 2021 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 26 Oct 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 26 Oct 2021 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 26 Oct 2021 Indirect

Insider Reports Filed by SV7 Impact Medicine Fund LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 26 Oct 2021 10 +$10,000,000 4/A 10%+ Owner 03 Nov 2021, 16:20
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 10%+ Owner 21 Oct 2021, 20:40